Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
USWM, LLC (dba US WorldMeds)
National Cancer Institute (NCI)
Immatics Biotechnologies GmbH
M.D. Anderson Cancer Center
Eli Lilly and Company
AstraZeneca
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Bayer
Boston Scientific Corporation
Amgen
National Institutes of Health Clinical Center (CC)
Norwegian Institute of Public Health
Norwegian Institute of Public Health
Massachusetts General Hospital
Boehringer Ingelheim
GRAIL, Inc.
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
EMD Serono
Janssen Research & Development, LLC
Hoffmann-La Roche
St. Jude Children's Research Hospital
Janssen Research & Development, LLC
GRAIL, Inc.
TOLREMO therapeutics AG
National Institutes of Health Clinical Center (CC)
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
USWM, LLC (dba US WorldMeds)
Peter MacCallum Cancer Centre, Australia
Amgen
M.D. Anderson Cancer Center
University of Utah
Georgetown University
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
AstraZeneca
University of Oklahoma
Astellas Pharma Inc
Actuate Therapeutics Inc.
Novartis
Grupo Espanol de Tumores Neuroendocrinos
Tempus AI
Pfizer